Over the past fifty years, Marek’s disease—an illness of fowl—has become fouler. Marek’s is caused by a highly contagious virus, related to those that cause herpes in humans. It spreads through the dust of contaminated chicken coops, and caused both paralysis and cancer. In the 1970s, new...
Published July 27, 2015
• 7 min read
Over the past fifty years, Marek’s disease
—an illness of fowl—has become fouler. Marek’s is caused by a highly contagious virus, related to those that cause herpes in humans. It spreads through the dust of contaminated chicken coops, and caused both paralysis and cancer. In the 1970s, new vaccines brought the disease the under control. But Marek’s didn’t go gently into that good night. Within ten years, it started evolving into more virulent strains, which now trigger more severe cancers and afflict chickens at earlier ages.
from Pennsylvania State University thinks that the vaccines were responsible. The Marek’s vaccine is “imperfect” or “leaky.” That is, it protects chickens from developing disease, but doesn’t stop them from becoming infected or from spreading the virus. Inadvertently, this made it easier for the most virulent strains to survive. Such strains would normally kill their hosts so quickly that they’d die out. But in an immunised flock, they can persist because their lethal nature has been neutered. That’s not a problem for vaccinated individuals. But unvaccinated birds are now in serious trouble.
This problem, where vaccination fosters the evolution of more virulent disease, does not apply
to most human vaccines. Those against mumps, measles, rubella, and smallpox are “perfect:” They protect against disease and
stop people from transmitting the respective viruses. “You don’t get onward evolution,” says Read. “These vaccines are very successful, highly effective, and very safe. They have been a tremendous success story and will continue to be so.”
He is more concerned about the next generation of vaccines that are being developed against diseases like HIV and malaria. People don’t naturally develop life-long immunity to these conditions after being infected, as they would against, say, mumps or measles. This makes vaccine development a tricky business, and it means that the resulting vaccines will probably leak to some extent. “This isn’t an argument against developing those vaccines, but it is
an argument for ensuring that we carefully check for transmission,” says Read.
“The candidate Ebola vaccines are also foremost in my mind,” he adds. “Some of the monkey trials suggest that they may be perfect, but we need to be very confident that they don’t leak. If they do, and some vaccinated individuals are capable of passing on Ebola, that might lead to the evolution of very dangerous pathogens.”